NASDAQ · Biotechnology

Aurinia Pharmaceuticals Inc (AUPH)

$14.70 -1.28%
32 In band Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 200$15.71-6.43%

Company profile

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is headquartered in Victoria, Canada.

SectorHealthcare
IndustryBiotechnology
Market cap$2.17B
P/E ratio7.11
EPS$2.28
Beta1.342
Dividend yield0.00%
52-week high$19.25
52-week low$13.52

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for AUPH

An email when AUPH closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 3:10 AM EST